Doctor profile · Federal record

Dr. Shahrooz Eshaghian, M.D.

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Internal Medicine Physician · Los Angeles, CA

  • NPI 1417132499
  • Accepts Medicare
  • MIPS 96.9 / 100 · 2023
  • 20 yrs in practice
  • Male
  • Solo practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
2080 Century Park E Ste 1005
Los Angeles, CA 900672013
(310) 229-3535

Credentials & registration

NPPES · NUCC
NPI registered
January 2008 — 18 yrs on file
Profile last updated
March 7, 2023
Year of graduation
2006 — 20 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
California #A100734

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1417132499. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
161,825
Distinct HCPCS
10
Medicare allowed
$2,908,876
HCPCS Description Services Patients Avg allowed
J1439 Injection, ferric carboxymaltose, 1 mg 90,000 64 $1
J0897 Injection, denosumab, 1 mg 22,762 154 $23
J9271 Injection, pembrolizumab, 1 mg 11,437 13 $54
J1437 Injection, ferric derisomaltose, 10 mg 7,800 76 $20
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes 5,419 535 $85
J1100 Injection, dexamethasone sodium phosphate, 1 mg 5,146 106 $0
99214 Established patient office or other outpatient visit, 30-39 minutes 2,093 614 $141
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 1,564 519 $8
96127 Assessment of emotional or behavioral problems 1,519 686 $5
36415 Insertion of needle into vein for collection of blood sample 1,261 518 $8

In context: peer comparison

Among 50 peers in this city , average services per provider: 1,244. This provider delivers 130× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$4,893
Transactions
127
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
BeiGene USA, Inc. 3 $1,649.68
AstraZeneca Pharmaceuticals LP 10 $334.74
Daiichi Sankyo Inc. 30 $312.64
Novartis Pharmaceuticals Corporation 16 $217.24
Astellas Pharma US Inc 6 $209.35
E.R. Squibb & Sons, L.L.C. 18 $181.00
Janssen Biotech, Inc. 13 $177.96
Incyte Corporation 5 $115.34
PFIZER INC. 5 $112.64
SOBI, INC 4 $96.20
GlaxoSmithKline, LLC. 4 $90.90
Genentech USA, Inc. 4 $85.96
Regeneron Healthcare Solutions, Inc. 3 $78.37
Lilly USA, LLC 3 $75.71
ABBVIE INC. 3 $74.87

By nature of payment

Food and Beverage
$3,138
Consulting Fee
$1,625
Education
$130

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,551
Patients
307
Total drug cost
$2,882,422
Drug Type Claims Patients Total cost
Eliquis (Apixaban) Brand 381 82 $266,760
Dutasteride Generic 154 35 $8,861
Orgovyx (Relugolix) Brand 137 19 $541,396
Acyclovir Generic 114 16 $1,851
Finasteride Generic 98 26 $1,786
Procrit (Epoetin Alfa) Brand 90 22 $224,422
Dexamethasone Generic 81 17 $971
Hydroxyurea Generic 68 0 $1,111
Dexamethasone Sodium Phosphate Generic 67 17 $369
Diphenhydramine Hcl Generic 65 17 $220

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Shahrooz Eshaghian's medical specialty?
Dr. Shahrooz Eshaghian practices Hematology & Oncology Physician in Los Angeles, CA.
Where does Dr. Shahrooz Eshaghian practice?
Dr. Shahrooz Eshaghian practices at 2080 Century Park E Ste 1005, Los Angeles, CA 900672013. Office phone: 3102293535.
What is Dr. Shahrooz Eshaghian's NPI?
Dr. Shahrooz Eshaghian's National Provider Identifier (NPI) is 1417132499, issued by NPPES.
Does Dr. Shahrooz Eshaghian accept Medicare assignment?
Yes. Dr. Shahrooz Eshaghian accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Shahrooz Eshaghian commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, denosumab, 1 mg (HCPCS J0897); Injection, pembrolizumab, 1 mg (HCPCS J9271). Source: CMS Medicare Physician & Other Practitioners file.